Journal article
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium
Abstract
Although the availability of effective novel treatments has positively impacted the quality of life and survival of newly diagnosed multiple myeloma (MM) patients, benefits in the transplant ineligible MM population may be limited by functional/frailty status. The Canadian Myeloma Research Group Consensus Guideline Consortium proposes consensus recommendations for the first-line treatment of transplant ineligible MM. To address the needs of …
Authors
Côté J; Kotb R; Bergstrom DJ; LeBlanc R; Mian HS; Othman I; Louzada ML
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 23, No. 5, pp. 340–354
Publisher
Elsevier
Publication Date
May 2023
DOI
10.1016/j.clml.2023.01.016
ISSN
2152-2650